FDA Stops Short Of Opiates Recall After Product Mix-Up At Novartis Plant
By
Brenda Sandburg / Email the Author / “The Pink Sheet” DAILY Jan. 9, 2012
Word Count: 837 / Article # 14120109008
Executive Summary
The agency issued a public health advisory warning pharmacists and patients to inspect bottles of opiate products made at the plant, including Endo’s Percocet and Percodan, for improper pills; an FDA official says the risk-benefit analysis is different for Novartis OTC products, which were voluntarily recalled.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.